Lineage-committed osteoclast precursors circulate in blood and settle down into bone

Journal of Bone and Mineral Research

Volumn 26, Issue 12, 2011, Pages 2978-2990

  Muto, Akinori ^a   Mizoguchi, Toshihide ^a   Udagawa, Nobuyuki ^a   Ito, Susumu ^b   Kawahara, Ichiro ^a   Abiko, Yoshimitsu ^c   Arai, Atsushi ^a   Harada, Suguru ^a   Kobayashi, Yasuhiro ^a   Nakamichi, Yuko ^a   Penninger, Josef M ^d   Noguchi, Toshihide ^e   Takahashi, Naoyuki ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^e AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

BLOODSTREAM; OSTEOCLAST PRECURSORS; OSTEOCLASTS; QUIESCENT; RANK

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BROXURIDINE; CELL MARKER; COLLAGEN; COLONY STIMULATING FACTOR 1; FYT 720; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SPHINGOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BONE; BONE CELL; BONE MARROW CELL; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL NUCLEUS; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MOUSE; NONHUMAN; OSTEOCLAST; PHAGOCYTOSIS; PRECURSOR; QUIESCENT OSTEOCLAST PRECURSOR;

ANIMALS; BIOLOGICAL MARKERS; BLOOD; BONE AND BONES; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; BROMODEOXYURIDINE; CELL LINEAGE; CELL MOVEMENT; CELL NUCLEUS; MACROPHAGES; MICE; OSTEOCLASTS; OSTEOCYTES; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; STEM CELLS;

EID: 80053927750     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.490     Document Type: Article

References (59)

1. Chambers TJ,. Regulation of the differentiation and function of osteoclasts. J Pathol. 2000; 192: 4-13.
2. Martin TJ, Romas E, Gillespie MT,. Interleukins in the control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr. 1998; 8: 107-23. (Pubitemid 30152112)
3. Roodman GD,. Cell biology of the osteoclast. Exp Hematol. 1999; 27: 1229-41. (Pubitemid 29347472)
4. Arron JR, Choi Y,. Bone versus immune system. Nature. 2000; 408: 535-6.
5. Boyle WJ, Simonet WS, Lacey DL,. Osteoclast differentiation and activation. Nature. 2003; 423: 337-42. (Pubitemid 40852708)
6. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL,. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 2000; 15: 2-12. (Pubitemid 30026926)
7. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ,. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999; 20: 345-57. (Pubitemid 30649812)
8. Suzawa T, Miyaura C, Inada M, et al. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology. 2000; 141: 1554-9. (Pubitemid 32269125)
9. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89: 309-19. (Pubitemid 27199902)
10. Udagawa N, Takahashi N, Yasuda H, et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology. 2000; 141: 3478-84. (Pubitemid 32269038)
11. Yasuda H, Shima N, Nakagawa N, et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology. 1998; 139: 1329-37. (Pubitemid 28510154)
12. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93: 165-76. (Pubitemid 28180851)
13. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998; 95: 3597-602.
14. Mizoguchi T, Muto A, Udagawa N, et al. Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. J Cell Biol. 2009; 184: 541-54.
15. Yamamoto Y, Udagawa N, Matsuura S, et al. Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-κB ligand. Endocrinology. 2006; 147: 3366-74. (Pubitemid 43901128)
16. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM,. Mechanisms of TNF-α- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest. 2003; 111: 821-31. (Pubitemid 37074957)
17. Vandooren B, Melis L, Veys EM, Tak PP, Baeten D,. In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes. Arthritis Rheum. 2009; 60: 1020-5.
18. Dalbeth N, Smith T, Nicolson B, et al. Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells. Arthritis Rheum. 2008; 58: 1854-65. (Pubitemid 351847541)
19. D'Amelio P, Grimaldi A, Di Bella S, et al. Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women. J Bone Miner Res. 2008; 23: 373-9. (Pubitemid 351304667)
20. Schwarz EM, Looney RJ, Drissi MH, et al. Autoimmunity and bone. Ann N Y Acad Sci. 2006; 1068: 275-83. (Pubitemid 43824159)
21. Mensah KA, Mathian A, Ma L, Xing L, Ritchlin CT, Schwarz EM,. Mediation of nonerosive arthritis in a mouse model of lupus by interferon-α- stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis. Arthritis Rheum. 2010; 62: 1127-37.
22. high osteoclast precursors in tumor necrosis factor α-transgenic mice. Arthritis Rheum. 2004; 50: 265-76. (Pubitemid 38084312)
23. Yao Z, Li P, Zhang Q, et al. Tumor necrosis factor-α increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem. 2006; 281: 11846-55. (Pubitemid 43855445)
24. hi osteoclast precursors but is essential for mature osteoclast formation in TNF-α-mediated inflammatory arthritis. J Bone Miner Res. 2004; 19: 207-13. (Pubitemid 38116734)
25. Huang W, O'Keefe RJ, Schwarz EM,. Exposure to receptor-activator of NFκB ligand renders pre-osteoclasts resistant to IFN-γ by inducing terminal differentiation. Arthritis Res Ther. 2003; 5: R49-59.
26. Ishii M, Egen JG, Klauschen F, et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009; 458: 524-8.
27. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999; 397: 315-23.
28. Takahashi N, Akatsu T, Udagawa N, et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology. 1988; 123: 2600-2.
29. Li X, Udagawa N, Takami M, Sato N, Kobayashi Y, Takahashi N,. p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology. 2003; 144: 4999-5005. (Pubitemid 37378415)
30. Mochizuki A, Takami M, Kawawa T, et al. Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-κB ligand. J Immunol. 2006; 177: 4360-8. (Pubitemid 44469764)
31. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A. 1990; 87: 2220-4.
32. Kawamoto T, Shimizu M,. A method for preparing 2- to 50-micron-thick fresh-frozen sections of large samples and undecalcified hard tissues. Histochem Cell Biol. 2000; 113: 331-9. (Pubitemid 30341300)
33. Jacquin C, Gran DE, Lee SK, Lorenzo JA, Aguila HL,. Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res. 2006; 21: 67-77. (Pubitemid 43023228)
34. Miyamoto T, Ohneda O, Arai F, et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood. 2001; 98: 2544-54.
35. Czeloth N, Bernhardt G, Hofmann F, Genth H, Forster R,. Sphingosine-1-phosphate mediates migration of mature dendritic cells. J Immunol. 2005; 175: 2960-7. (Pubitemid 41170513)
36. Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, Cyster JG,. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science. 2005; 309: 1735-9. (Pubitemid 41285945)
37. Wakkach A, Mansour A, Dacquin R, et al., Bone marrow microenviroment controls the in vivo differentiation of murine dendritic cells into osteoclasts. Blood. 2008; 15: 5074-83.
38. Niida S, Amizuka N, Hara F, Ozawa H, Kodama H,. Expression of Mac-2 antigen in the preosteoclast and osteoclast identified in the op/op mouse injected with macrophage colony-stimulating factor. J Bone Miner Res. 1994; 9: 873-81. (Pubitemid 24178070)
39. Kim K, Kim JH, Lee J, et al. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood. 2007; 109: 3253-9. (Pubitemid 46572510)
40. Zhao B, Takami M, Yamada A, et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med. 2009; 15: 1066-71.
41. Nishikawa K, Nakashima T, Hayashi M, et al. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation. Proc Natl Acad Sci U S A. 2010; 107: 3117-22.
42. Grigoriadis AE, Wang ZQ, Cecchini MG, et al. c-Fos: a key regulator of osteoclast-macrophage linage determination and bone remodeling. Science. 1994; 266: 443-8.
43. Ashizuka S, Peranteau WH, Hayashi S, Flake AW,. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation. Exp Hematol. 2006; 34: 359-68.
44. Fujisaki J, Wu J, Carlson AL, et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature. 2011; 474: 216-9.
45. Niederkorn JY,. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol. 2006; 7: 354-9.
46. Lin H, Lee E, Hestir K, et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science. 2008; 320: 807-11. (Pubitemid 351929632)
47. 3. J Bone Miner Res. 2009; 24 (Suppl 1). Available at. Accessed September 17, 2011.
48. Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med. 2000; 191: 275-86.
49. Kim N, Kadono Y, Takami M, et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med. 2005; 202: 589-95. (Pubitemid 41248411)
50. Li J, Sarosi I, Yan XQ, et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A. 2000; 97: 1566-71. (Pubitemid 30118482)
51. Arai F, Miyamoto T, Ohneda O, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J Exp Med. 1999; 190: 1741-54. (Pubitemid 30013841)
52. Kaplan FS, Glaser DL, Shore EM, et al. Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am. 2007; 89: 347-57. (Pubitemid 46214354)
53. Scheven BA, Kawilarang-De Haas EW, Wassenaar AM, Nijweide PJ,. Differentiation kinetics of osteoclasts in the periosteum of embryonic bones in vivo and in vitro. Anat Rec. 1986; 214: 418-23. (Pubitemid 16078835)
54. Blavier L, Delaisse JM,. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci. 1995; 108: 3649-59. (Pubitemid 26004028)
55. Engsig MT, Chen QJ, Vu TH, et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol. 2000; 151: 879-89.
56. Maes C, Kobayashi T, Selig MK, et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell. 2010; 19: 329-44.
57. Fischman DA, Hay ED,. Origin of osteoclasts from mononuclear leucocytes in regenerating newt limbs. Anat Rec. 1962; 143: 329-37.
58. Omatsu Y, Sugiyama T, Kohara H, et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity. 2010; 33: 387-99.
59. Ara T, Tokoyoda K, Sugiyama T, Egawa T, Kawabata K, Nagasawa T,. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity. 2003; 19: 257-67. (Pubitemid 37011340)